Form 10-Q REGENERON PHARMACEUTICAL For: Jun 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. LEN
7. NVDA
8. USO
9. LMT
10. AMZN

Go back to Form 10-Q REGENERON PHARMACEUTICAL For: Jun 30

Roth Keeps Regeneron (REGN) at 'Buy' Following Q2 Report; Says 'Blocking and Tackling' Continues

August 4, 2016 2:55 PM EDT

Roth Capital affirms Regeneron (Nasdaq: REGN) with a Buy rating and $520 price target following Q2 results and updated guidance, as reported... More